IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,502,113 | -11.7% | 549,915 | +36.7% | 0.00% | 0.0% |
| Q2 2023 | $2,832,311 | +605.7% | 402,317 | +512.5% | 0.00% | – |
| Q1 2023 | $401,330 | -38.4% | 65,684 | -35.6% | 0.00% | – |
| Q4 2022 | $651,262 | +11.7% | 101,919 | +67.6% | 0.00% | – |
| Q3 2022 | $583,000 | -59.4% | 60,818 | -53.3% | 0.00% | -100.0% |
| Q2 2022 | $1,436,000 | -85.1% | 130,117 | -77.5% | 0.00% | -66.7% |
| Q1 2022 | $9,622,000 | +40.2% | 577,920 | +60.7% | 0.00% | +50.0% |
| Q4 2021 | $6,865,000 | -12.5% | 359,617 | +13.1% | 0.00% | -33.3% |
| Q3 2021 | $7,843,000 | -46.9% | 318,034 | -43.9% | 0.00% | -50.0% |
| Q2 2021 | $14,758,000 | +182.8% | 567,196 | +244.2% | 0.01% | +100.0% |
| Q1 2021 | $5,218,000 | -62.3% | 164,787 | -44.8% | 0.00% | -57.1% |
| Q4 2020 | $13,844,000 | +42.1% | 298,337 | +0.8% | 0.01% | +40.0% |
| Q3 2020 | $9,742,000 | -40.6% | 295,908 | -50.4% | 0.01% | -58.3% |
| Q2 2020 | $16,390,000 | +189.4% | 597,098 | +215.6% | 0.01% | +100.0% |
| Q1 2020 | $5,664,000 | +599.3% | 189,213 | +546.8% | 0.01% | +500.0% |
| Q4 2019 | $810,000 | +35.0% | 29,255 | -11.3% | 0.00% | 0.0% |
| Q3 2019 | $600,000 | -42.7% | 32,982 | -22.8% | 0.00% | -50.0% |
| Q2 2019 | $1,048,000 | +539.0% | 42,724 | +101.5% | 0.00% | +100.0% |
| Q3 2017 | $164,000 | – | 21,204 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |